Elsevier Inc.

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Abu-Rustum
    Abu-Rustum
  3. Chi
    Chi
  4. O'Cearbhaill
    O'Cearbhaill
  5. Iasonos
    Iasonos
  6. Sabbatini
    Sabbatini
  7. Zhou
    Zhou
  8. Hensley
    Hensley
  9. Tew
    Tew
  10. Makker
    Makker

Groups

  1. Department of Medicine (189)
  2. GDMT, Medicine (189)
  3. Gynecologic Medicine Service (189)
  4. Gynecology Disease Management Team (189)
  5. Solid Tumor Oncology Division (189)
  6. Surgery (93)
  7. GDMT, Surgery (85)
  8. Epidemiology and Biostatistics (51)
  9. Biostatistics Service (47)
  10. GDMT, Pathology and Laboratory Medicine (42)
Search Within
  1. "Carol Aghajanian"
  2. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (129)
  2. Meeting Abstract (59)
  3. Correspondence (1)
Groups
  1. Department of Medicine (189)
  2. GDMT, Medicine (189)
  3. Gynecologic Medicine Service (189)
  4. Gynecology Disease Management Team (189)
  5. Solid Tumor Oncology Division (189)
  6. Surgery (93)

More Groups

People
  1. Carol Aghajanian (189)
  2. Nadeem Abu-Rustum (59)
  3. Dennis Chi (45)
  4. Paul Sabbatini (41)
  5. Richard Barakat (37)
  6. Roisin O'Cearbhaill (36)

More People

Years
  1. 2024 (3)
  2. 2023 (15)
  3. 2022 (15)
  4. 2021 (15)
  5. 2020 (23)
  6. 2019 (8)

More Years

Publications
  1. Gynecologic Oncology (174)
  2. Seminars in Oncology (6)
  3. European Journal of Cancer (3)
  4. International Journal of Radiation Oncology, Biology, Physics (3)
  5. Journal of Geriatric Oncology (2)
  6. Community Oncology (1)

Results (189)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study
    Journal Article

    Westin, S. N.; Sill, M. W.; Coleman, R. L.; Waggoner, S.; Moore, K. N.; Mathews, C. A.; Martin, L. P.; Modesitt, S. C.; Lee, S.; Ju, Z.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study
    Journal Article

    O'Cearbhaill, R. E.; Deng, W.; Chen, L. M.; Lucci, J. A. 3rd; Behbakht, K.; Spirtos, N. M.; Muller, C. Y.; Benigno, B. B.; Powell, M. A.; Berry, E.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Positron emission tomography to evaluate response in the cervix and lymph nodes after definitive chemoradiation and immunotherapy for cervical cancer patients treated on GOG 9929
    Meeting Abstract

    Mayadev, J. S.; Enserro, D.; Ghamande, S.; Moore, K.; Lin, Y.; DaSilva, D.; Aghajanian, C.; Schilder, R.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Molecular profiling and molecular classification of endometrioid ovarian carcinomas
    Journal Article

    Cybulska, P.; Da Cruz Paula, A.; Tseng, J.; Leitao, M. M. Jr; Bashashati, A.; Huntsman, D. G.; Nazeran, T. M.; Aghajanian, C.; Abu-Rustum, N. R.; DeLair, D. F.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients
    Journal Article

    Fuh, K. C.; Java, J. J.; Chan, J. K.; Kapp, D. S.; Monk, B. J.; Burger, R. A.; Young, R. C.; Alberts, D. S.; McGuire, W. P.; Markman, M.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Matulonis, U. A.; Sill, M. W.; Makker, V.; Mutch, D. G.; Carlson, J. W.; Darus, C. J.; Mannel, R. S.; Bender, D. P.; Crane, E. K.; Aghajanian, C.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Monk, B. J.; Kauderer, J. T.; Moxley, K. M.; Bonebrake, A. J.; Dewdney, S. B.; Secord, A. A.; Ueland, F. R.; Johnston, C. M.; Aghajanian, C.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save